SMART-TRIAL will be attending the EU Medical Device Post-Market Clinical Evaluation Planning conference in Frankfurt on October 29th & 30th.

This conference brings together professionals from leading medical device companies to share their insights and practical examples for tackling the PMCF under the MDR. ‘The EU Medical Device Post-Market Clinical Evaluation Planning Conference will provide insight into practical solutions implemented by medical device firms to determine the appropriate level of evidence needed and to develop plans to meet enhanced post-market clinical follow-up requirements’

We are pleased to be exhibiting SMART-TRIAL and look forward to meeting industry peers. Additionally, Jón Ingi Bergsteinsson our VP of Global Business Development will be presenting a talk on Collecting Clinical Evidence in a Post-Market setting – Three Success stories.

Collecting Clinical Evidence in a Post-Market setting – Three Success stories

As it goes, planning and executing a successful post-market clinical data collection strategy is a challenge. The lack of examples of how PMCF studies are to be conducted leaves many uneasy. The requirements for clinical evidence vary depending on the device type and classification, but “proactive” remains a keyword within the regulation. In his talk, Jón will be focused on three different cases of PMCF studies, based on real use cases from manufacturers that have had success with proactive data collection. The goal is to inspire other manufacturers, and provide guidance for implementing a successful post-market data collection strategy under the MDR. His is scheduled to present on October 30th at 10:15 am.

You can also meet our CEO, Páll Jóhannesson and the team at our stand to see how SMART-TRIAL facilitates faster PMCF studies. 

We look forward to seeing you there Contact Us to schedule a meeting on site or if you have any questions.

For more information on the conference visit: https://www.q1productions.com/eu-pmclinical/